Criticism of the rescheduling of conjunctivitis treatment, Chloramphenicol, as a Schedule 3 (S3) medicine, is being seen as an attack on medication continuance.
Pharmacy Guild of Australia president Kos Sclavos told Pharmacy eNews the AMA had insulted the profession by suggesting pharmacists were not capable of treating eye infections .
Questioning the AMA’s decision yesterday to comment on the National Drugs and Poisons Scheduling Committee decision to reschedule Chloramphenicol — previously a Schedule 4 medication - as a S3 therapy from 1 May, Mr Sclavos said it was more to do with the Federal Government’s decision to approve medical continuance.
“I just can’t believe they’re coming out with this. This was flagged and people made submissions a year ago, it...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.